Janus Henderson Group’s NxStage Medical Inc. NXTM Stock Holding History

Janus Henderson Group’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,320	Closed	-$209K	–	1423
2018 Q4	$209K	Sell	7,320 -3,185	-30%	-$90.5K	﹤0.01%	1312
2018 Q3	$293K	Buy	10,505 +2,134	+25%	+$60K	﹤0.01%	1386
2018 Q2	$234K	Buy	+8,371	New	+$224K	﹤0.01%	1356
2017 Q3	–	Sell	-454,339	Closed	-$11.4M	–	1358
2017 Q2	$11.4M	Sell	454,339 -19,291	-4%	-$478K	0.01%	852
2017 Q1	$12.7M	Buy	+473,630	New	+$13.1M	0.09%	247

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Janus Henderson Group's NXTM Position: Q1 2019 in Review

Janus Henderson Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 7,320 shares — an estimated $209K sold.

Janus Henderson Group first reported a position in NXTM in Q1 2017 and held it in 5 quarters. The position peaked at $12.7M in Q1 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Janus Henderson Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Janus Henderson Group sold 7,320 NxStage Medical Inc. shares in Q1 2019, an estimated $209K.
Janus Henderson Group first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 5 quarters.
Janus Henderson Group's NxStage Medical Inc. position peaked at $12.7M in Q1 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Janus Henderson Group's 13F filing for Q1 2019, filed 30 Apr 2019.